---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-151259"
form_type: "8-K"
ticker: "SLDB"
cik: "0001707502"
company_name: "Solid Biosciences Inc."
filed_at: "2026-04-10T23:59:59+00:00"
generated_at: "2026-05-15T06:41:29.032588+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Solid Biosciences reclassifies director Ilan Ganot from Class III to Class I to balance board composition

## Summary
- Ilan Ganot resigned from Class III effective 4:00 p.m. ET on April 10, 2026.
- Board reduced Class III to three directors and increased Class I to three, appointing Ganot to Class I with term expiring at 2028 Annual Meeting.
- Ganot's compensation arrangements unchanged; no compensation due for resignation or appointment.
- Company will seek advisory ratification of Ganot's appointment as Class I Director at 2026 Annual Meeting.

## SEC filing metadata
- accession: 0001193125-26-151259
- form_type: 8-K
- ticker: SLDB
- cik: 0001707502
- company_name: Solid Biosciences Inc.
- filed_at: 2026-04-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1707502/000119312526151259/0001193125-26-151259-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1707502/000119312526151259/sldb-20260410.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-151259
- JSON: https://secwatch.observer/filing/0001193125-26-151259.json
- Plain text: https://secwatch.observer/filing/0001193125-26-151259.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.